- Filed
- May 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 12.38M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.95M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 7.46M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$1.23M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.6M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $100.74K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $7.08M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.97M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $5.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $258.48K |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.07M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.81M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.79M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.14M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $5.73M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $8.75M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $6.4M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.33 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.33 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.21M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $2.43M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $99.57K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $117.87K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.76M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.28M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.74M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.3M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.39M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $756.18K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $218.37K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $139.48K |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.61M |
| Revenue | Q1 2026 · Mar 31, 2025 | $895.66K |
| Capex | Q1 2026 · Mar 31, 2025 | $18K |